Conference Coverage

VIDEO: Genomics, other advances further highlight how breast cancer differs in men


 

AT MBCC

MIAMI BEACH – Growing evidence continues to point to a widening separation between female and male breast cancers, particularly with discoveries suggesting different pathways to disease and important genetic distinctions.

Therefore, the traditional practice of extrapolating findings from female breast cancer research to men with breast cancer no longer makes sense, Patrick I. Borgen, MD, said at the annual Miami Breast Cancer Conference, held by Physicians’ Education Resource.

The incidence of male breast cancer is increasing. At the same time, fewer men with breast cancer get referred for and undergo genetic testing for their disease, said Dr. Borgen, chair of the department of surgery at Maimonides Medical Center in Brooklyn, N.Y.

Dr. Borgen explained in a video interview that both maternal and paternal inheritance of breast cancer are important, and they tie the lineage into a hypothesis for why BRCA mutations – which can predispose people to worse survival – have persisted through generations.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Dr. Borgen is a member of the speakers bureau for Genomic Health Inc., NanoString Technologies, Genentech, and Pacira Inc.

Recommended Reading

Scalp cooling reduces hair loss in 50% or more of women in separate studies
MDedge Internal Medicine
Oral contraceptive use confers long-term cancer protection
MDedge Internal Medicine
‘Strong evidence’ links obesity to cancers
MDedge Internal Medicine
Breast cancer mortality mapped for 2017
MDedge Internal Medicine
VIDEO: HER2+ patients may do fine with local therapies alone
MDedge Internal Medicine
VIDEO: Registry studies reflect real patients in the real world
MDedge Internal Medicine
VIDEO: Vaccines, combination therapy hold most promise for optimizing immunotherapy in breast cancer
MDedge Internal Medicine
VIDEO: What’s new with HER2-neu inhibition
MDedge Internal Medicine
VIDEO: Multiple PARP inhibitors show promise in breast cancer treatment
MDedge Internal Medicine
VIDEO: It’s too early to give up on immunotherapy for breast cancer
MDedge Internal Medicine